Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.54 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.54 |
| ▸ | ADORA2A | P29274 | 18/20 | 0.53 |
| ▸ | ADORA2B | P29275 | 6/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20400244 | 1.00 | HSP90AA1 (0.54) | HSP90AA1HSP90AB1ADORA2AADORA2B | |
| SCHEMBL22763963 | 0.86 | ADORA2A (0.43) | ADORA2AADORA2B | |
| SCHEMBL31341441 | 0.85 | HSP90AA1 (0.64) | HSP90AA1HSP90AB1ADORA2AADORA2B | |
| SCHEMBL22763959 | 0.83 | ADORA2A (0.53) | ADORA2AADORA2B | |
| SCHEMBL20416534 | 0.83 | HSP90AA1 (0.54) | HSP90AA1HSP90AB1ADORA2A | |
| SCHEMBL29907836 | 0.83 | HSP90AA1 (0.54) | HSP90AA1HSP90AB1ADORA2A | |
| SCHEMBL30401919 | 0.83 | HSP90AA1 (0.58) | HSP90AA1HSP90AB1ADORA2A | |
| SCHEMBL20400253 | 0.83 | HSP90AA1 (0.58) | HSP90AA1HSP90AB1ADORA2A | |
| SCHEMBL30080309 | 0.81 | ADORA2A (0.49) | ADORA2AADORA2B | |
| SCHEMBL20416550 | 0.81 | ADORA2A (0.49) | ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119490483-A | 2-Aminopyrimidine compound derivative and application thereof | 复旦大学 | 2025-02-21 | — | — | CN | disclosed |
| CN-113429410-B | Polyheterocyclic substituted pyrimidine or pyridylamine derivatives, compositions and medical uses thereof | 上海海雁医药科技有限公司 | 2022-10-04 | — | — | CN | disclosed |